STM Journals Peer-reviewed research from Consortium e-Learning Network

Research and Reviews : A Journal of Ayurvedic Science, Yoga and Naturopathy Review Article

Terminalia arjuna: The Medicinal Tree

  1. Shreya V. Chaudhari Department of Pharmaceuticals, P.S.G.V.P Mandal’s College of Pharmacy, Shahada
  2. Sunil A. Patil Department of Pharmaceuticals, P.S.G.V.P Mandal’s College of Pharmacy, Shahada
  3. S.P. Pawar Department of Pharmaceuticals, P.S.G.V.P Mandal’s College of Pharmacy, Shahada

Abstract

Over 85% of the medications used in both conventional and alternative medical systems come from plant sources. The stem bark of Terminalia arjuna (T. arjuna) is rich in minerals, flavonoids, and glycosides. T. arjuna bark is unique because flavonoids have been shown to have anti-inflammatory, lipid-lowering, and antioxidant properties, and glycosides are cardiotonic. A variety of topics related to its ethnomedical, phytochemical, pharmacological, and clinical significance to different medical conditions have been attempted to be covered in this review. After superfluous information was removed, 60 articles were found in all. Most of the research, including both clinical and experimental studies, has indicated that T. arjuna bark has hypolipidemic, antioxidant, and anti-ischemic properties. Among its advantageous phytoconstituents are triterpenoids, flavonoids, glycosides, tannins, phenolics, and arjunolic acid. Experimental studies have demonstrated the potent antioxidant and cardioprotective properties of T. arjuna bark. Here is an extended version of your abstract with ~100 more words added in continuation, keeping the flow and scientific tone intact: Over 85% of the medications used in both conventional and alternative medical systems come from plant sources. The stem bark of T. arjuna is rich in minerals, flavonoids, and glycosides. T. arjuna bark is unique because flavonoids have been shown to have anti-inflammatory, lipid-lowering, and antioxidant properties, and glycosides are cardiotonic. A variety of topics related to its ethnomedical, phytochemical, pharmacological, and clinical significance to different medical conditions have been attempted to be covered in this review. After superfluous information was removed, 60 articles were found in all. Most of the research, including both clinical and experimental studies, has indicated that T. arjuna bark has hypolipidemic, antioxidant, and anti-ischemic properties. Among its advantageous phytoconstituents include triterpenoids, flavonoids, glycosides, tannins, phenolics, and arjunolic acid. Experimental studies have demonstrated the potent antioxidant and cardioprotective properties of T. arjuna bark. Furthermore, several clinical investigations have reported its beneficial effects in managing hypertension, coronary artery disease, and heart failure. The bark extracts have been observed to improve endothelial function, reduce oxidative stress, and enhance myocardial efficiency. In addition, studies suggest its potential role in modulating lipid metabolism and reducing serum cholesterol levels, thereby lowering cardiovascular risk factors. Its traditional use in Ayurveda as a heart tonic is now supported by increasing pharmacological evidence, making it a promising natural therapeutic agent. With rising interest in plant-based medicines, T. arjuna continues to gain attention as a safe, well-tolerated, and effective herbal option in cardiovascular health management

Keywords

References (25)

  1. Facts and benefits of Arjun tree. Health Benefits Times. 2018. Available at: https://www.healthbenefitstimes.com/arjun-tree/#google_vignette
  2. Niroga Institute. Niroga Institute. 2025. Available at: https://www.niroga.org/?srsltid= AfmBOorrw3SFD2iWeXN1x3MUnSNpWB5ADE2XJ8hD0RuHtCpSWddtWmEK
  3. Kokate CK, Purohit AP, Gokhale SB. Textbook of Pharmacognosy. 41st ed. Pune: Nirali Prakashan; 2008.
  4. Jayaraman S, Saha A, Pawar V. Characterisation of polyphenols in Terminalia arjuna bark extract. Indian Journal of Pharmaceutical Sciences. 2012;74(4):339. doi:10.4103/0250-474x.107067
  5. Ramachan L, Murti PS, Rao GS, Sastry CS, Rao KV. Chemical examination of Terminalia species. 13. Isolation and structure determination of arjunetin from Terminalia arjuna. Indian J Chem. 1970;8(9):772–775.
  6. Amalraj A, Gopi S. Medicinal properties of Terminalia arjuna (Roxb.) Wight & Arn.: A review. Journal of Traditional and Complementary Medicine. 2017;7(1):65-78. doi:10.1016/j.jtcme.2016.02.003
  7. Chung KT, Wong TY, Wei CI, Huang YW, Lin Y. Tannins and Human Health: A Review. Critical Reviews in Food Science and Nutrition. 1998;38(6):421-464. doi:10.1080/10408699891274273
  8. Kapoor D, Vijayvergiya R, Dhawan V. Terminalia arjuna in coronary artery disease: Ethnopharmacology, pre-clinical, clinical & safety evaluation. Journal of ethnopharmacology. 2014 Sep 11;155(2):1029-45.
  9. Dwivedi S. Terminalia arjuna Wight & Arn.—A useful drug for cardiovascular disorders. Journal of Ethnopharmacology. 2007;114(2):114-129. doi:10.1016/j.jep.2007.08.003
  10. Manna P, Sinha M, Sil PC. Aqueous extract of Terminalia arjuna prevents carbon tetrachloride induced hepatic and renal disorders. BMC Complementary and Alternative Medicine. 2006;6(1). doi:10.1186/1472-6882-6-33
  11. Devi RS, Narayan S, Vani G, Shyamala Devi CS. Gastroprotective effect of Terminalia arjuna bark on diclofenac sodium induced gastric ulcer. Chemico-Biological Interactions. 2007;167(1):71-83. doi:10.1016/j.cbi.2007.01.011
  12. Manna P, Sinha M, Sil PC. RETRACTED: Protection of Arsenic‐Induced Hepatic Disorder by Arjunolic Acid. Basic & Clinical Pharmacology & Toxicology. 2007;101(5):333-338. doi:10.1111/j.1742-7843.2007.00132.x
  13. Manna P, Sinha M, Pal P, Sil PC. Arjunolic acid, a triterpenoid saponin, ameliorates arsenic-induced cyto-toxicity in hepatocytes. Chemico-Biological Interactions. 2007;170(3):187-200. doi:10.1016/j.cbi.2007.08.001
  14. Mushke R, Yarra R, Kokkirala VR, Abbagani S. Cell, Tissue Culture, and Gene Transfer Techniques for Tasar (Wild) Sericulture Plants—Introspect and Prospect. Journal of Sustainable Forestry. 2014;33(2):173-183. doi:10.1080/10549811.2013.836719
  15. Salim SA. In vitro induction of callus from different explants of Terminalia arjuna (Roxb.) Wight & Arn. and detection of its active secondary metabolites using GC-MS analysis. Plant Archives. 2018;10(9):2519–2527.
  16. Arumugam A, Gopinath K. In-vitro Callus Development of Different Explants used for Different Medium of Terminalia arjuna. Asian Journal of Biotechnology. 2011;3(6):564-572. doi:10.3923/ajbkr.2011.564.572
  17. Agri Farming – Agriculture Livestock Gardening Aquaculture Horticulture Farming. 2023. Available at https://www.agrifarming.in/
  18. Dwivedi S, Chansouria JN, Somani PN, Udupa KN. Effect of Terminalia arjuna on ischaemic heart disease. Altern Med. 1989;3(2):115–122.
  19. Verma SK, Bordia A. Effect of Terminalia arjuna bark (arjunchhal) in patients of congestive heart failure and hypertension. J Res Educ Indian Med. 1988;7:316.
  20. Antani JA, Gandhi S, Antani NJ. Terminalia arjuna in congestive heart failure (Abstract). J Assoc Physicians India. 1991;39:801.
  21. Bhawani G, Kumar A, Murthy KSN, Kumari N, Ganapati Swami C. A retrospective study of effect of Terminalia arjuna and evidence based standard therapy on echocardiographic parameters in patients of dilated cardiomyopathy. Journal of Pharmacy Research. 2013;6(5):493-498. doi:10.1016/j.jopr.2013.05.006
  22. Tripathi VK, Singh B, Jha RN, Pandey VB, Udupa KN. Studies on Arjuna in coronary heart disease. J Res Ayur Siddha. 2000;21:37–40.
  23. Terminalia arjuna. Altern Med Rev J Clin Ther. 1999;4(6):436–437.
  24. Naveed M, Khalid H, Ayub MA, Rehman MZ, Rizwan M, Rasul A, Haq MA. Biofortification of cereals with zinc and iron: recent advances and future perspectives. Resources use efficiency in agriculture. 2020 Sep 19:615-46.
  25. Bharani A, Ganguly A, Bhargava KD. Salutary effect of Terminalia Arjuna in patients with severe refractory heart failure. International Journal of Cardiology. 1995;49(3):191-199. doi:10.1016/0167-5273(95)02320-v
Support